...
首页> 外文期刊>American Journal of Pathology >Early Dysregulation of Cell Adhesion and Extracellular Matrix Pathways in Breast Cancer Progression
【24h】

Early Dysregulation of Cell Adhesion and Extracellular Matrix Pathways in Breast Cancer Progression

机译:乳腺癌进展中细胞粘附和细胞外基质途径的早期失调。

获取原文
获取原文并翻译 | 示例
           

摘要

Proliferative breast lesions, such as simple ductal hyperplasia (SH) and atypical ductal hyperplasia (ADH), are candidate precursors to ductal carcinoma in situ (DCIS) and invasive cancer. To better understand the relationship of breast lesions to more advanced disease, we used microdissection and DNA microarrays to profile the gene expression of patient-matched histologically normal (HN), ADH, and DCIS from 12 patients with estrogen receptor positive sporadic breast cancer. SH were profiled from a subset of cases. We found 837 differentially expressed genes between DCIS-HN and 447 between ADH-HN, with >90% of the ADH-HN genes also present among the DCIS-HN genes. Only 61 genes were identified between ADH-DCIS. Expression differences were reproduced in an independent cohort of patient-matched lesions by quantitative real-time PCR. Many breast cancer-related genes and pathways were dysregulated in ADH and maintained in DCIS. Particularly, cell adhesion and extracellular matrix interactions were overrepresented. Focal adhesion was the top pathway in each gene set. We conclude that ADH and DCIS share highly similar gene expression and are distinct from HN. In contrast, SH appear more similar to HN. These data provide genetic evidence that ADH (but not SH) are often precursors to cancer and suggest cancer-related genetic changes, particularly adhesion and extracellular matrix pathways, are dysregulated before invasion and even before malignancy is apparent. These findings could lead to novel risk stratification, prevention, and treatment approaches.
机译:乳腺增生性病变,例如单纯性导管增生(sup> (SH)和非典型导管增生(ADH))是导管原位癌(DCIS)和浸润性癌的候选前体 。为了更好地 了解乳腺病变与更晚期 疾病的关系,我们使用显微解剖和DNA微阵列技术对 患者匹配的基因表达进行了组织学分析。 12名雌激素受体 阳性散发性乳腺癌患者的正常 (HN),ADH和DCIS。 SH是根据病例的子集 进行分析的。我们发现 DCIS-HN之间有837个差异表达基因,而ADH-HN之间有447个差异表达基因,其中超过90%的ADH-HN基因 也存在于DCIS-HN基因中。在ADH-DCIS之间仅发现了61个基因。通过定量 实时PCR在独立的患者匹配病变队列中再现表达差异。在ADH中,许多与乳腺癌相关的基因和途径 均失调,而在DCIS中则得以维持。特别是, 细胞粘附和细胞外基质相互作用被过分代表。 粘着是每个基因组中的主要途径。我们得出的结论 :ADH和DCIS具有高度相似的基因表达,并且与HN有明显区别。相比之下,SH似乎与HN更相似。 这些数据提供了遗传证据,证明ADH(而非SH)通常是癌症的前兆,并暗示与癌症相关的遗传因素 变化,特别是粘附和细胞外基质途径, 在侵袭之前甚至在恶性 明显之前就失调了。这些发现可能导致新的风险分层, 预防和治疗方法。

著录项

  • 来源
    《American Journal of Pathology》 |2009年第3期|1292-1302|共11页
  • 作者单位

    From the Departments of Medicine,Boston University Medical Center, Boston, Massachusetts;

    From the Departments of Medicine,Boston University Medical Center, Boston, Massachusetts;

    From the Departments of Medicine,Boston University Medical Center, Boston, Massachusetts;

    Surgery,Boston University Medical Center, Boston, Massachusetts;

    Surgery,Boston University Medical Center, Boston, Massachusetts;

    Surgery,Boston University Medical Center, Boston, Massachusetts;

    Pathology,Boston University Medical Center, Boston, Massachusetts;

    and Biostatistics,Boston University Medical Center, Boston, Massachusetts;

    From the Departments of Medicine,Boston University Medical Center, Boston, Massachusetts|Pathology,Boston University Medical Center, Boston, Massachusetts;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号